Correlation Between UPDATE SOFTWARE and Jazz Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both UPDATE SOFTWARE and Jazz Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UPDATE SOFTWARE and Jazz Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UPDATE SOFTWARE and Jazz Pharmaceuticals plc, you can compare the effects of market volatilities on UPDATE SOFTWARE and Jazz Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UPDATE SOFTWARE with a short position of Jazz Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of UPDATE SOFTWARE and Jazz Pharmaceuticals.

Diversification Opportunities for UPDATE SOFTWARE and Jazz Pharmaceuticals

-0.27

Correlation Coefficient

UPDATE SOFTWARE  Jazz Pharmaceuticals

Very good diversification

The 3 months correlation between UPDATE and Jazz is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding UPDATE SOFTWARE and Jazz Pharmaceuticals plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jazz Pharmaceuticals plc and UPDATE SOFTWARE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UPDATE SOFTWARE are associated (or correlated) with Jazz Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jazz Pharmaceuticals plc has no effect on the direction of UPDATE SOFTWARE i.e., UPDATE SOFTWARE and Jazz Pharmaceuticals go up and down completely randomly.

Pair Corralation between UPDATE SOFTWARE and Jazz Pharmaceuticals

Assuming the 90 days trading horizon UPDATE SOFTWARE is expected to under-perform the Jazz Pharmaceuticals. In addition to that, UPDATE SOFTWARE is 1.85 times more volatile than Jazz Pharmaceuticals plc. It trades about -0.1 of its total potential returns per unit of risk. Jazz Pharmaceuticals plc is currently generating about 0.09 per unit of volatility. If you would invest  11,685  in Jazz Pharmaceuticals plc on December 20, 2024 and sell it today you would earn a total of  1,025  from holding Jazz Pharmaceuticals plc or generate 8.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

UPDATE SOFTWARE  vs.  Jazz Pharmaceuticals plc

UPDATE SOFTWARE

Risk-Adjusted Performance

Very Weak

Over the last 90 days UPDATE SOFTWARE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Jazz Pharmaceuticals plc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Jazz Pharmaceuticals plc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Jazz Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with UPDATE SOFTWARE and Jazz Pharmaceuticals

The main advantage of trading using opposite UPDATE SOFTWARE and Jazz Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UPDATE SOFTWARE position performs unexpectedly, Jazz Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jazz Pharmaceuticals will offset losses from the drop in Jazz Pharmaceuticals' long position.

The idea behind UPDATE SOFTWARE and Jazz Pharmaceuticals plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.